We are live on
!
Find out more
Immunic
IMUX
IMUX
55 hedge funds and large institutions have $35M invested in Immunic in 2016 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 12 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
119% more call options, than puts
Call options by funds: $219K | Put options by funds: $100K
42% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 12
8% more funds holding
Funds holding: 51 → 55 (+4)
0.07% more ownership
Funds ownership: 0% → 0.07% (+0.07%)
32% less capital invested
Capital invested by funds: $51.5M → $35M (-$16.6M)
Holders
55
Holders Change
+4
Holders Change %
+7.84%
% of All Funds
1.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
17
Reduced
12
Closed
4
Calls
$219K
Puts
$100K
Net Calls
+$119K
Net Calls Change
-$95K
Top Buyers
| 1 |
Millennium Management
New York
|
+$1.04M |
| 2 |
Morgan Stanley
New York
|
+$348K |
| 3 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$339K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$274K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$263K |
Top Sellers
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.79M |
| 2 |
AI
ArchPoint Investors
Coral Gables,
Florida
|
-$184K |
| 3 |
ProShare Advisors
Bethesda,
Maryland
|
-$136K |
| 4 |
Goldman Sachs
New York
|
-$94.2K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$81K |
